Phase 2CompletedAge-related condition
Efficacy and Safety of S (+) - Ibuprofen in Osteoarthritis Pain (APS003/2020)
National, Multicentre, Randomized, Double-blind, Double-dummy Phase II Clinical Trial to Evaluate the Efficacy and Safety of S (+) - Ibuprofen for Pain Control in Individuals With Osteoarthritis
- Sponsor
- Apsen Farmaceutica S.A. (Industry)
- Enrollment
- 176 enrolled
- Conditions
- Osteoarthritis
- Interventions
- S (+) - Ibuprofen; Ibuvix® - ibuprofen
- Ages
- adults, older adults
- Registry
- NCT04637529
Full record on ClinicalTrials.gov
From the registry
The purpose of this study is to evaluate the efficacy of S (+) - ibuprofen compared to an active treatment for pain control in individuals diagnosed with osteoarthritis.
Primary outcomes
- Mean reduction of pain measured by the WOMAC Osteoarthritis Index (pain)
History
Last registry update
Primary completion
Started
Registered